If you have been diagnosed with liver cancer in Canada, you want the services of an exceptional surgeon for any recommended treatments. Dr. Dmitri Alden is a renowned surgeon specializing in cancer surgeries, including liver cancer. His state-of-the-art practice in NYC serves patients from everywhere, including across the U.S. northern border. Dr. Alden is a top-rated liver cancer surgeon serving Canada, and patients can easily travel to his clinic in New York for multidisciplinary, custom liver surgery for adults or children with all stages of liver disease.

Dmitri Alden, MD performs more than 200+ liver and bile duct surgeries a year as part of the comprehensive customized services he offers, including advanced diagnostics, treatments, liver surgery, transplantation and various means of support after your treatment is completed. With over 6,000 successful surgeries in the past two decades, Dr. Alden is uniquely qualified to perform your liver cancer surgery. Patients in Canada will find it worth the trip to his NYC practice to benefit from laparoscopic and robotic liver cancer surgery that results in:

• Faster healing and recovery
• Shorter hospital stays
• Fast access to any additional therapies
• Exceptional cosmetic outcomes

Dr. Alden is listed among America’s Top 100 Surgeons by the Consumers Research Council of America for his achievements as a specialist.

Hepatocellular Carcinoma (HCC) Primary Liver Cancer Oncological Surgeon

Also known as primary liver cancer, hepatocellular carcinoma (HCC) is a tumor that forms inside a patient’s liver. HCC is not a metastasis type of cancer that spreads into the liver from other locations in the body, but it is a common complication of liver cirrhosis. Most patients in North America with HCC have alcoholic cirrhosis or hepatitis C that causes their cancer. As a talented and experienced liver cancer oncological surgeon in NYC, Dr. Alden determines the cause of each patient’s HCC to determine the best form of treatment; the tumors behave differently according to their primary cause.

Primacy liver cancer, or HCC, is extremely common, comprising 95% of liver cancer cases. Current statistics reveal that almost four million people in the US have hepatitis C, and many of them can be expected to develop primary liver cancer, or HCC. Hepatocellular carcinoma tumors are typically detected through advanced imaging, including ultrasound, CT scan or MRI with contrast studies. A positive scan is usually followed up with an alfa-fetoprotein (AFP) marker test.

Best HCC Cancer Surgeon in NYC Serving Canada

Dr. Alden provides a top-rated concierge environment and surgical experience at his clinic in NYC. We accept full out of network insurance benefits and are happy to handle your claim submissions from our office. Our professional surgical coordinator can provide a quote of costs as well as assist with travel arrangements from Canada, accommodations and more.

Treatments for each patient are generally based on the number of tumors, their size and location, as well as any underlying conditions that can include ascites, hepatitis C, esophageal varices or portal hypertension. Dr. Alden works with a talented multidisciplinary team to manage your liver cancer treatment and other conditions to produce the best outcomes. Treating your cancer medically, chemically or surgically is determined by a range of factors, as well as candidacy for a liver transplantation.

As the best HCC cancer surgeon in NYC serving Canada, Dr. Alden prefers cancer resection surgery when possible as the best method to remove tumors with a less risk of recurrence. However, when a resection is not possible, he may recommend a minimally invasive microwave ablation (MWA) to destroy the tumor cells and arterial embolization to cut off the blood supply to the tumor. Both of these treatments are effective and can sometimes be combined with chemoembolization.

Contact NYC Liver, pancreatic & bile duct oncological surgeon, Dmitri Alden, MD, FACS today by phone at (212) 434-6216, or contact us online to learn more about traveling to NYC from Canada for hepatocellular carcinoma (HCC) / primary liver cancer surgery.